Is Your Pain Management Clinic Ready to Sell?

Buyers and SBA lenders require clean, professionally prepared financials. Ensure all three years reflect true business performance with personal and practice expenses fully separated. Co-mingled expenses — personal vehicle, personal insurance, family payroll — must be clearly identified and normalized in a seller's discretionary earnings or EBITDA add-back schedule.

Work with a healthcare-experienced CPA to document all legitimate owner add-backs including above-market physician salary, one-time legal fees, personal travel, and discretionary spending. Buyers will scrutinize this document closely — unsupported add-backs erode trust and reduce offers.

Review your AR aging report and eliminate balances over 120 days that are unlikely to collect. Resolve any outstanding claim disputes with Medicare, Medicaid, or commercial payers. High AR days or write-off exposure signals poor revenue cycle management to buyers and reduces perceived cash flow quality.

Confirm your practice pays you a market-rate salary documented in a formal employment agreement. Excess distributions or informal compensation arrangements create audit risk and confuse buyers trying to model post-acquisition cash flows. Normalize compensation to a replacement physician cost if you plan to exit the business.

Create a detailed revenue schedule showing collections by service line (interventional procedures, medication management, physical therapy, ancillary services) and by payer (commercial, Medicare, Medicaid, workers' comp, self-pay). Buyers pay premium multiples for practices with diversified, procedure-heavy revenue and strong commercial payer concentration.

Hire a healthcare compliance attorney or consultant to review your DEA registration status, Schedule II–IV prescribing patterns, and documentation practices. Identify any prescribing outliers, missing documentation, or PDMP compliance gaps before a buyer's due diligence team does. Unresolved compliance issues are the single most common deal-killer in pain management acquisitions.

Confirm that all prescribers in your practice are registered and compliant with your state's PDMP requirements. Document your standard protocols for checking PDMP prior to prescribing controlled substances. Buyers will request prescribing records and want evidence of systematic compliance, not ad hoc practices.

Pull your Medicare cost reports, remittance advices, and any RAC or ZPIC audit correspondence from the past three years. Resolve any open overpayment notices or recoupment demands. Undisclosed billing compliance issues discovered during due diligence can trigger indemnification demands or deal restructuring.

If your practice has reduced reliance on opioid prescribing and expanded interventional procedures (nerve blocks, spinal injections, neuromodulation), quantify and document that trend. Buyers and lenders view an interventional-forward model as more defensible, more reimbursable, and lower regulatory risk.

Obtain a five-year claims history from your malpractice carrier and prepare a summary of any open litigation, settlements, or disciplinary actions. Ensure your tail coverage is addressed in your exit planning. Buyers will require representations and warranties on litigation history and will factor open claims into deal pricing.

Every employed or contracted physician should have a current, written employment agreement with enforceable non-compete and non-solicitation provisions appropriate for your state. Buyers acquiring a pain management clinic need assurance that clinical staff will remain post-close. Physicians without written agreements are a major due diligence red flag.

Systematically begin transitioning long-term patients to associate physicians. Document patient assignment protocols and track patient retention rates per physician. If 70%+ of revenue traces to a single founding physician, buyers will apply a significant key-person discount or require a multi-year earnout to protect against patient attrition.

Key non-clinical staff — billing manager, front desk supervisor, medical assistant leads — carry significant institutional knowledge. Confirm their compensation is competitive, document their roles, and consider retention bonuses tied to deal close. Buyers will interview these employees during due diligence.

Prepare a written transition plan describing how a new owner or incoming clinical director will be integrated into the practice. Include patient communication protocols, referral source introductions, and a 90-day handoff schedule. Buyers pay more for practices that make the ownership transition feel manageable.

Compile a complete payer contract schedule including all commercial insurers, Medicare Advantage plans, workers' compensation carriers, and managed care agreements. Review each contract for assignment clauses — most require advance notice or re-credentialing upon ownership change. Failing to address this pre-close can result in payer terminations and revenue disruption after the deal closes.

Hire a certified professional coder or revenue cycle consultant to audit a representative sample of claims for coding accuracy, upcoding, undercoding, and documentation support. Calculate your denial rate and days in AR. Practices with denial rates above 10% or AR days above 50 signal billing system weakness to buyers.

If any major commercial payer contracts are expiring within 12 months or are below market rates, renegotiate now. A practice under contract renegotiation at time of sale introduces uncertainty that buyers price into their offers. Locked-in, favorable payer rates support a more predictable revenue forecast and higher multiple.

Confirm your electronic medical records system is on a supported version, that you own or can transfer your data, and that the system can be either continued by a buyer or migrated to their preferred platform. Outdated or physician-locked EMR systems create transition costs buyers deduct from their offers.

Engage a healthcare attorney experienced in your state's corporate practice of medicine (CPOM) doctrine before going to market. Many buyers — especially PE-backed MSOs and non-physician acquirers — will require an MSO structure. Understanding your state's rules and preparing compliant deal documents in advance prevents months of legal delay during closing.

Work with your M&A advisor and tax counsel to model the after-tax proceeds from an asset purchase versus a stock sale and understand the MSO structure if applicable. Pain management clinics typically transact as asset purchases with SBA financing, but PE buyers often prefer stock purchases or earnout structures tied to physician retention. Know your preferred structure before entering negotiations.

Retain an M&A advisor or business broker with demonstrated experience in healthcare and pain management practice transactions. They will prepare a confidential information memorandum, run a structured buyer process, and negotiate deal terms on your behalf. Sellers who go to market unrepresented typically leave 15–25% of deal value on the table.

Commission a formal fair market value opinion from a credentialed healthcare valuation firm (CVAHP or ABV designation). This establishes a defensible asking price, supports SBA lender appraisal requirements, and prevents you from either under-pricing your practice or anchoring too high and losing credible buyers early in the process.

Work with your advisor to produce a detailed CIM covering your practice history, service line mix, payer relationships, physician team, financial performance, and growth opportunities. A well-prepared CIM signals professionalism, accelerates buyer due diligence, and reduces deal fatigue that kills transactions in extended processes.